Literature DB >> 10465339

Dietary zinc deficiency enhances esophageal cell proliferation and N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumor incidence in C57BL/6 mouse.

L Y Fong1, P N Magee.   

Abstract

The effect of zinc deficiency on N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumor formation in rats has been well documented. Our previous work showed that zinc deficiency and its associated increased esophageal cell proliferation were of paramount importance in esophageal tumor development in the NMBA-rat model. However, there has been no report concerning zinc deficiency and NMBA-induced esophageal tumor formation in mice. In this study, weanling C57BL/6 mice were fed ad libitum with either a zinc-sufficient or a zinc-deficient diet containing 3-4 ppm of zinc, and received six intragastric doses of NMBA (2 mg/kg; twice weekly for 3 weeks). The animals were sacrificed 46 weeks later after in vivo bromodeoxyuridine (BrDU) labeling followed by immunohistochemical detection of cells in S-phase. At 46 weeks, the tumor incidences in zinc-deficient mice were 57, 100, and 100% respectively, in the esophagus, forestomach and squamocolumnar junction with the glandular stomach (SCJ), as compared to 17, 39, and 67% in the corresponding tissue of zinc-sufficient mice. The difference between the two dietary groups was significant at P < 0.02 for the esophagus, and P < 0.001 for the forestomach and the SCJ. BrDU labeling revealed that the esophageal labeling index and the number of labeled cells were increased by zinc deficiency. These results support a role of increased cell proliferation in esophageal carcinogenesis in the mouse.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465339     DOI: 10.1016/s0304-3835(99)00191-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

1.  Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains.

Authors:  Jin Sun; James Liu; Xueliang Pan; Donald Quimby; Nicola Zanesi; Teresa Druck; Gerd P Pfeifer; Carlo M Croce; Louise Y Fong; Kay Huebner
Journal:  Carcinogenesis       Date:  2010-11-19       Impact factor: 4.944

2.  Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line.

Authors:  Emily Ho; Bruce N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-12       Impact factor: 11.205

3.  FHIT gene therapy prevents tumor development in Fhit-deficient mice.

Authors:  K R Dumon; H Ishii; L Y Fong; N Zanesi; V Fidanza; R Mancini; A Vecchione; R Baffa; F Trapasso; M J During; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 4.  Zinc and gastrointestinal disease.

Authors:  Sonja Skrovanek; Katherine DiGuilio; Robert Bailey; William Huntington; Ryan Urbas; Barani Mayilvaganan; Giancarlo Mercogliano; James M Mullin
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

5.  Extracellular zinc stimulates ERK-dependent activation of p21(Cip/WAF1) and inhibits proliferation of colorectal cancer cells.

Authors:  Ki-Sook Park; Yongho Ahn; Jin-Ah Kim; Mi-Sun Yun; Baik L Seong; Kang-Yell Choi
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

6.  Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1.

Authors:  Sangyong Choi; Chaochu Cui; Yanhong Luo; Sun-Hee Kim; Jae-Kyun Ko; Xiaofang Huo; Jianjie Ma; Li-Wu Fu; Rhonda F Souza; Irina Korichneva; Zui Pan
Journal:  FASEB J       Date:  2017-09-19       Impact factor: 5.191

7.  Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo.

Authors:  Rami I Aqeilan; John P Hagan; Haifa A Aqeilan; Flavia Pichiorri; Louise Y Y Fong; Carlo M Croce
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

8.  Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: inefficacy of genetic or pharmacological disruption of COX-2.

Authors:  Louise Y Y Fong; Yubao Jiang; Maurisa Riley; Xianglan Liu; Karl J Smalley; Denis C Guttridge; John L Farber
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

9.  Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient mice.

Authors:  David J Feith; Anthony E Pegg; Louise Y Y Fong
Journal:  Carcinogenesis       Date:  2012-12-07       Impact factor: 4.944

Review 10.  Environmental causes of esophageal cancer.

Authors:  Farin Kamangar; Wong-Ho Chow; Christian C Abnet; Sanford M Dawsey
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.